Reducing peritonitis rates in a peritoneal dialysis program of indigent ethnic minorities

Peritoneal Dialysis International

Volumn 23, Issue 1, 2003, Pages 83-85

  Mehrotra, Rajnish ^a,b,c   Marwaha, Tarun ^a   Berman, Nancy ^a,b,d   Mason, Greg ^a,b,c   Appell, Marilyn ^a   Kopple, Joel D ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DATA ANALYSIS; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0037235329     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300113     Document Type: Article

References (8)

1. United States Renal Data System. Bethesda, MD: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health; 2001.
2. Korbet SM, Shih D, Cline KN, Vonesh EF. Racial differences in survival in an urban peritoneal dialysis program. Am J Kidney Dis 1999; 34:713-20.
3. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20:828-9]. Perit Dial Int 2000; 20:396-411.
4. Vonesh E. Modeling peritonitis rates and associated risk factors for individuals on continuous ambulatory peritonitis. Stat Med 1990; 9:263-71.
5. Vonesh EF, Chinchilli VM. Linear and Nonlinear Models for the Analysis of Repeated Measurements. New York: Marcel Dekker; 1997.
6. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27:695-700.
7. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site [see Comments]. Perit Dial Int 1998; 18:261-70.
8. Casey M, Taylor J, Clinard P, Graham A, Mauck V, Spainhour L, et al. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20:566-8.